Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845091 · ClinicalTrials.gov registry record · Phase 1
Cardiac Autonomic Regulation Enhancement Through Exercise Trial
A Phase 1 study of Cardiovascular Disease, Arrhythmias, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT00845091: Completed Phase 1 study of Cardiovascular Disease, Arrhythmias, sponsored by The Miriam Hospital.
NCT00845091 is a Phase 1 study of Cardiovascular Disease, Arrhythmias that has completed, run by The Miriam Hospital. The registered enrollment target is 22 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00845091, a Phase 1 study of Cardiovascular Disease, Arrhythmias, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The current research study proposes to examine participants with implantable cardioverter defibrillators (ICD) who are randomly assigned to either an exercise training program intervention or a heart healthy education program intervention. We will look at changes in the functioning of the autonomic nervous system over time and between intervention groups. We are also going to be looking at changes in frequencies of the ICD participants' heart arrhythmias and ICD therapies (e.g., pacing, shock).; as well as, changes in exercise tolerance, psychological well-being, and quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Heart Healthy Education
Study Locations (1)
Rhode Island
- The Miriam Hospital Centers for Behavioral and Preventive Medicine - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
What the finished NCT00845091 record still lists
NCT00845091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Cardiovascular Disease, Arrhythmias appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT00845091 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00845091 about?
NCT00845091 is a clinical study titled "Cardiac Autonomic Regulation Enhancement Through Exercise Trial". The current research study proposes to examine participants with implantable cardioverter defibrillators (ICD) who are randomly assigned to either an exercise training program intervention or a heart healthy education program intervention. We will look at changes in the functioning of the autonomic ...
What is the current status of trial NCT00845091?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2009-02. Estimated completion is 2011-07.
What conditions does trial NCT00845091 study?
This clinical trial studies the following conditions: Cardiovascular Disease, Arrhythmias.
What interventions are being tested in trial NCT00845091?
The interventions under investigation include: Exercise (BEHAVIORAL), Heart Healthy Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00845091?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00845091 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00845091's enrollment target sits among peer trials
22 1601st of 2000 higher than 386 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia